Candidate SNP Markers of Reproductive Potential Predicted by Significant Change in Affinity of TATA-Binding Protein for Human Gene Promoters

    February 2018 in “ BMC Genomics
    Irina Chadaeva, П. М. Пономаренко, Д. А. Рассказов, Ekaterina Sharypova, Е. В. Кашина, Dmitry Zhechev, И. А. Драчкова, Olga Arkova, Л. К. Савинкова, М. П. Пономаренко, Nikolay А. Kolchanov, Л. В. Осадчук, Alexandr Osadchuk
    Image of study
    TLDR Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.
    Chadaeva et al. conducted a study to identify single nucleotide polymorphisms (SNPs) that could serve as markers of reproductive potential by affecting the affinity of TATA-binding protein (TBP) for gene promoters. They used a web service to analyze over 1000 SNPs and identified 126 candidate SNP markers. Some of these SNPs were associated with risks of thrombosis, myocardial infarction, and various cancers, while others were linked to blood diseases like malaria resistance and thalassemia. The study also found candidate SNPs related to conditions such as androgenetic alopecia, pre-eclampsia, and hyperandrogenism. In vitro experiments like electrophoretic mobility shift assay (EMSA) and cell culture transfection experiments were used to validate the effects of some candidate SNPs on TBP affinity and gene expression. The findings suggest that these SNPs are under strong natural selection pressure and could be used to personalize medical advice and interventions, potentially improving reproductive outcomes and longevity. The study supports the concept of predictive-preventive personalized medicine based on individual genome sequences, although the number of participants or samples was not specified in the summary provided.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 8 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community Spironolactine Update: 2 months (34, Female)

      in Female  20 upvotes 7 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Similar Research

    5 / 1000+ results